Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sakae Tanaka

Showing results (1-10 of 913) with videos related to

Pageof 92
Sort By:
World Journal of Orthopedics|January 31, 2013
Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathwaysSakae Tanaka
Modern Rheumatology|October 10, 2006
Intracellular signal transduction pathways: good therapeutic targets for joint destruction in rheumatoid arthritisSakae Tanaka
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|August 5, 2018
Emerging anti-osteoclast therapy for rheumatoid arthritisSakae Tanaka
Clinical Calcium|July 5, 2005
[A novel therapeutic vaccine approach against RANKL that prevents pathological bone destruction]Sakae Tanaka
Clinical Calcium|June 3, 2005
[Disorder of bone quality in osteopetrosis]Sakae Tanaka
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|November 27, 2025
The evolving role of orthopaedics in Japan: A century of progress and a vision for the futureSakae Tanaka
Clinical Calcium|January 27, 2017
[Effects of zoledronic acid on osteoporosis patients in Japan.]Sakae Tanaka
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 9, 2017
RANKL-Independent Osteoclastogenesis: A Long-Standing ControversySakae Tanaka
F1000Research|May 10, 2019
RANKL is a therapeutic target of bone destruction in rheumatoid arthritisSakae Tanaka
Clinical Calcium|March 19, 2005
[Therapeutic vaccination approach against pathological bone disease]Sakae Tanaka
Pageof 92

Showing results (1-10 of 913) with videos related to

Sort By:
Pageof 92
World Journal of Orthopedics|January 31, 2013
Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathwaysSakae Tanaka
Modern Rheumatology|October 10, 2006
Intracellular signal transduction pathways: good therapeutic targets for joint destruction in rheumatoid arthritisSakae Tanaka
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|August 5, 2018
Emerging anti-osteoclast therapy for rheumatoid arthritisSakae Tanaka
Clinical Calcium|July 5, 2005
[A novel therapeutic vaccine approach against RANKL that prevents pathological bone destruction]Sakae Tanaka
Clinical Calcium|June 3, 2005
[Disorder of bone quality in osteopetrosis]Sakae Tanaka
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|November 27, 2025
The evolving role of orthopaedics in Japan: A century of progress and a vision for the futureSakae Tanaka
Clinical Calcium|January 27, 2017
[Effects of zoledronic acid on osteoporosis patients in Japan.]Sakae Tanaka
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 9, 2017
RANKL-Independent Osteoclastogenesis: A Long-Standing ControversySakae Tanaka
F1000Research|May 10, 2019
RANKL is a therapeutic target of bone destruction in rheumatoid arthritisSakae Tanaka
Clinical Calcium|March 19, 2005
[Therapeutic vaccination approach against pathological bone disease]Sakae Tanaka
Pageof 92